Yahoo Web Search

Search results

    • Sino Biopharmaceutical Ltd's Dividend Analysis

      Sino Biopharmaceutical Ltd's Dividend Analysis

      GuruFocus.com via Yahoo Finance· 5 days ago

      As of 2023, innovative and biosimilar drugs contribute 37.8% to its revenue, with oncology being the largest segment at 33.6%. Other significant areas...